Initial Public Offers (ipos)

Ultra-luxury focus, capital-light model, and strong project pipeline underpin value creation

Macleods Pharmaceuticals defers big-bang listing plans; will PE funds step in now?

Moneycontrol was the first to report the listing plans of Macleods Pharma on July 25, 2021. According to its DRHP, the firm’s proposed IPO consists purely of an OFS from the promoter group comprising 60.5 million shares and the size was expected to be around Rs 5,000 crore.

Lessons to learn from Paytm, Zomato & other IPOs before applying for LIC’s shares

As the markets turned volatile, investors were reminded of the old lessons around ‘greed and fear’ in various ways. There’s lots to learn from recently listed stocks like Paytm and Zomato while making an informed decision about applying to the LIC IPO. Here’s a checklist to keep in mind.

Moneycontrol Pro Panorama | It’s raining public offers and investors are spoilt for choice

In today’s edition of Moneycontrol Pro Panorama: IPOs’ gale force, the capex juggernaut moves, recovery stutters, right call for Airtel, Policybazaar’s moat, the growing muscle of quants, and more

UTI AMC: Good long-term bet available at reasonable price

UTI being the second largest asset management company (AMC), on the basis of total AUM, and eighth largest, in terms of MF quarterly average assets as of June, will continue to be one of the key beneficiaries of the enduring growth in the mutual fund industry.

IPOs in India likely to raise USD 5 billion in 2016: EY

"IPOs in India are set to hit a six-year high in 2016 as the companies looking to go public, supported by a growing appetite for equities and an uptick in economic growth, are estimated to raise more than USD 5 billion," EY said.

Cos garner Rs 7000 cr via NCDs in first 8 months of FY15

Market experts said fund raising via NCDs has been less, compared to the year-ago period as companies have preferred QIPs and rights issues.